Lexapro(escitalopram) is approved in China for the treatment of depression and panic disorder with or without agoraphobia.
Lexapro acts by special mechanism. It is the only SSRI which binds both the primary site and allosteric site on the serotonin transporter , and the inhibition of serotonin reuptake is greatly improved. So it has acute effect on anxiety symptoms.
Lexapro can work fast and can relieve depression in 1 week. According to clinical trials report, the remission rate is up to 53.9%, the advantages are significant especially for moderate to severe depressed patients. It has been shown less adverse events, and rare interaction with other drugs, therefore, it is one of the most safe antidepressant drugs at present.Lexapro is researched and synthesized by H. Lundbeck A/S in Denmark, and approved by Switzerland in Europe in 2002. After 10 years development, Lexapro has been available in about 100 countries all over the world, and more than 290 million patients with depression or anxiety benefit from the treatment of it.
Because of remarkable response and safety, it has become the first choice for depression and anxiety patients.
Please consult medical experts for information on products or call Lundbeck China office.